Y Intercept Hong Kong Ltd Invests $745,000 in Haleon PLC Sponsored ADR (NYSE:HLN)

Key Points

• Y Intercept Hong Kong Ltd has acquired a new stake in Haleon PLC Sponsored ADR, purchasing 72,374 shares valued at approximately $745,000 in the first quarter.
• Multiple institutional investors, including Bartlett & CO. Wealth Management and Opal Wealth Advisors, have significantly increased their holdings in Haleon recently, highlighting growing interest in the company.
• Haleon has seen various ratings changes by brokerages, including a "strong-buy" upgrade from BNP Paribas, while the average price target is currently set at $12.33.

Y Intercept Hong Kong Ltd bought a new position in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 72,374 shares of the company's stock, valued at approximately $745,000.

A number of other institutional investors also recently bought and sold shares of HLN. Farther Finance Advisors LLC grew its holdings in shares of Haleon by 8.8% during the 1st quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company's stock worth $131,000 after purchasing an additional 1,041 shares during the period. Apollon Wealth Management LLC grew its holdings in shares of Haleon by 5.4% during the 1st quarter. Apollon Wealth Management LLC now owns 21,722 shares of the company's stock worth $224,000 after purchasing an additional 1,111 shares during the period. Simplicity Wealth LLC grew its holdings in shares of Haleon by 7.9% during the 1st quarter. Simplicity Wealth LLC now owns 15,482 shares of the company's stock worth $159,000 after purchasing an additional 1,135 shares during the period. Bessemer Group Inc. lifted its stake in Haleon by 5.9% during the 4th quarter. Bessemer Group Inc. now owns 22,301 shares of the company's stock worth $212,000 after acquiring an additional 1,236 shares in the last quarter. Finally, United Capital Financial Advisors LLC lifted its stake in Haleon by 3.5% during the 4th quarter. United Capital Financial Advisors LLC now owns 37,475 shares of the company's stock worth $358,000 after acquiring an additional 1,266 shares in the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HLN. Wall Street Zen lowered Haleon from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Morgan Stanley upgraded shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective for the company in a report on Friday, May 9th. BNP Paribas Exane upgraded shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective for the company in a report on Tuesday, May 27th. BNP Paribas upgraded shares of Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. Finally, Barclays restated an "overweight" rating on shares of Haleon in a report on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, four have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Haleon currently has an average rating of "Moderate Buy" and a consensus price target of $12.33.

Haleon Stock Down 1.6%

Shares of NYSE:HLN traded down $0.16 on Wednesday, hitting $9.65. 12,478,726 shares of the company's stock were exchanged, compared to its average volume of 11,349,267. The firm's 50-day moving average is $10.44 and its 200 day moving average is $10.18. The company has a market capitalization of $43.35 billion, a PE ratio of 24.74, a P/E/G ratio of 2.84 and a beta of 0.25. Haleon PLC Sponsored ADR has a 1-year low of $8.86 and a 1-year high of $11.42. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.78 and a current ratio of 0.98.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.